198 related articles for article (PubMed ID: 23508835)
1. Intraductal papillary neoplasm of the bile ducts: description of MRI and added value of diffusion-weighted MRI.
Yoon HJ; Kim YK; Jang KT; Lee KT; Lee JK; Choi DW; Lim JH
Abdom Imaging; 2013 Oct; 38(5):1082-90. PubMed ID: 23508835
[TBL] [Abstract][Full Text] [Related]
2. Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation.
Park MJ; Kim YK; Lim S; Rhim H; Lee WJ
Radiology; 2014 Mar; 270(3):768-76. PubMed ID: 24475800
[TBL] [Abstract][Full Text] [Related]
3. Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T.
Lim S; Kim YK; Park HJ; Lee WJ; Choi D; Park MJ
J Magn Reson Imaging; 2014 May; 39(5):1238-45. PubMed ID: 24136725
[TBL] [Abstract][Full Text] [Related]
4. Imaging features of intrahepatic cholangiocarcinoma in Gd-EOB-DTPA-enhanced MRI.
Péporté AR; Sommer WH; Nikolaou K; Reiser MF; Zech CJ
Eur J Radiol; 2013 Mar; 82(3):e101-6. PubMed ID: 23159401
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical outcome of the surgically resected intraductal papillary neoplasm of the bile duct.
Jung G; Park KM; Lee SS; Yu E; Hong SM; Kim J
J Hepatol; 2012 Oct; 57(4):787-93. PubMed ID: 22634127
[TBL] [Abstract][Full Text] [Related]
6. Detection of small hepatocellular carcinoma using gadoxetic acid-enhanced MRI: Is the addition of diffusion-weighted MRI at 3.0T beneficial?
Zhao XT; Li WX; Chai WM; Chen KM
J Dig Dis; 2014 Mar; 15(3):137-45. PubMed ID: 24354621
[TBL] [Abstract][Full Text] [Related]
7. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
[TBL] [Abstract][Full Text] [Related]
8. Differentiating combined hepatocellular and cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma using gadoxetic acid-enhanced MRI.
Hwang J; Kim YK; Park MJ; Lee MH; Kim SH; Lee WJ; Rhim HC
J Magn Reson Imaging; 2012 Oct; 36(4):881-9. PubMed ID: 22730271
[TBL] [Abstract][Full Text] [Related]
9. Detection of liver malignancy with gadoxetic acid-enhanced MRI: is addition of diffusion-weighted MRI beneficial?
Kim YK; Kim CS; Han YM; Lee YH
Clin Radiol; 2011 Jun; 66(6):489-96. PubMed ID: 21367403
[TBL] [Abstract][Full Text] [Related]
10. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
Kim AY; Kim YK; Lee MW; Park MJ; Hwang J; Lee MH; Lee JW
Acta Radiol; 2012 Oct; 53(8):830-8. PubMed ID: 22847903
[TBL] [Abstract][Full Text] [Related]
11. Gd-EOB-DTPA-enhanced magnetic resonance imaging for bile duct intraductal papillary mucinous neoplasms.
Ying SH; Teng XD; Wang ZM; Wang QD; Zhao YL; Chen F; Xiao WB
World J Gastroenterol; 2015 Jul; 21(25):7824-33. PubMed ID: 26167082
[TBL] [Abstract][Full Text] [Related]
12. Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma.
Park MJ; Kim YK; Park HJ; Hwang J; Lee WJ
J Comput Assist Tomogr; 2013; 37(6):872-81. PubMed ID: 24270108
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
Kang Y; Lee JM; Kim SH; Han JK; Choi BI
Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
[TBL] [Abstract][Full Text] [Related]
14. Morphological classification of intraductal papillary neoplasm of the bile duct.
Ying S; Ying M; Liang W; Wang Z; Wang Q; Chen F; Xiao W
Eur Radiol; 2018 Apr; 28(4):1568-1578. PubMed ID: 29138880
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
[TBL] [Abstract][Full Text] [Related]
16. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
17. Cyst-forming intraductal papillary neoplasm of the bile ducts: description of imaging and pathologic aspects.
Lim JH; Zen Y; Jang KT; Kim YK; Nakanuma Y
AJR Am J Roentgenol; 2011 Nov; 197(5):1111-20. PubMed ID: 22021503
[TBL] [Abstract][Full Text] [Related]
18. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
Park HJ; Kim YK; Park MJ; Lee WJ
Abdom Imaging; 2013 Aug; 38(4):793-801. PubMed ID: 22829097
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound Findings of Intraductal Papillary Neoplasm in Bile Duct and the Added Value of Contrast-Enhanced Ultrasound.
Liu LN; Xu HX; Zheng SG; Sun LP; Guo LH; Zhang YF; Xu JM; Liu C; Xu XH
Ultraschall Med; 2015 Dec; 36(6):594-602. PubMed ID: 25188491
[TBL] [Abstract][Full Text] [Related]
20. Gadoxetic acid-enhanced MRI with MR cholangiography for the preoperative evaluation of bile duct cancer.
Sun HY; Lee JM; Park HS; Yoon JH; Baek JH; Han JK; Choi BI
J Magn Reson Imaging; 2013 Jul; 38(1):138-47. PubMed ID: 23281093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
